eFFECTOR Therapeutics, Inc. (EFTR) Earnings
|
Expand Research on EFTR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +61.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/24 | Q124 | -$2.16 | -$3.00 | +$0.84 | N/A | N/A | N/A |  | | Details | |
| 3/13/24 | Q423 | N/A | -$2.42 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23  |
Q323 | -$0.13 | -$0.13 | $0.00 | N/A | N/A | N/A | | | Details | |
| 11/6/23 | Q323 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/8/23 | Q223 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/15/23 | Q422 | N/A | -$0.24 | N/A | N/A | $664.4K | N/A | N/A | N/A | ||
| 11/7/22 | Q322 | $0.42 | -$0.17 | +$0.59 | $427K | $642.2K | N/A | | | Details |
